Transgenomic Reports Increased Revenues, Widened Loss in Q4; Eyes Profitability in Q4 02 | GenomeWeb

NEW YORK, Jan. 30 - Transgenomic on Wednesday said that its fourth-quarter losses widened as increased sales of its gene analysis equipment and chemicals failed to counter a jump in operating expenses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."